Table 4.
Overall prescribing patterns and guideline compliance for adult acute bronchitis at primary healthcare in China.
| Drug subgroup/substance | Prescription rate (weighted, %) |
Guideline compliance rate, CN (weighted, %) | Guideline compliance rate, US (weighted, %) | Guideline compliance rate, UK (weighted, %) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | Urban | Rural | p | Total | Urban | Rural | p | Total | Urban | Rural | p | Total | Urban | Rural | p | |
| Antibiotics, only | 17.3 | 17.2 | 17.4 | 0.8 | 1.5 | 0.0 | * | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | – | |
| Symptom management drugs, only | 36.1 | 39.5 | 31.5 | *** | 37.0 | 29.9 | 49.1 | *** | 2.7 | 3.0 | 2.3 | 27.5 | 24.1 | 33.3 | *** | |
| Antibiotics+symptom management drugs a | 29.1 | 22.1 | 38.6 | *** | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | – | 0.0 | 0.0 | 0.0 | – |
| Not treated with drugs | 17.5 | 21.2 | 12.6 | *** | 100.0 | 100.0 | 100.0 | – | 100.0 | 100.0 | 100.0 | – | 100.0 | 100.0 | 100.0 | – |
| Total | 100.0 | 100.0 | 100.0 | – | 31.0 | 33.2 | 28.0 | *** | 18.5 | 22.3 | 13.3 | *** | 27.4 | 30.7 | 23.1 | *** |
CN China, US the United States, UK the United Kingdom.
*p < 0.05; **p < 0.01; ***p < 0.001.
aPrescriptions were treated as complied if both antibiotics and symptom management drugs were complied with guidelines.